SCHEMBL30240911

SCHEMBL30240911

COc1cc(C(=O)O)cc(O)c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TPMT P51580 6/20 1.00
▸ PTGS2 P35354 1/20 0.72
▸ CA12 O43570 3/20 0.66
▸ CA1 P00915 3/20 0.66
▸ CA2 P00918 3/20 0.66
▸ CA4 P22748 3/20 0.66
▸ CA6 P23280 3/20 0.66
▸ CA7 P43166 3/20 0.66
▸ CA9 Q16790 3/20 0.66
▸ CA14 Q9ULX7 3/20 0.66
▸ CA3 P07451 2/20 0.66
▸ CA5A P35218 2/20 0.66
▸ CA5B Q9Y2D0 2/20 0.66
▸ PKM P14618 1/20 0.66
▸ HTT P42858 1/20 0.59
▸ TUBB4A P04350 2/20 0.56
▸ TUBB P07437 2/20 0.56
▸ TUBA3C P0DPH7 2/20 0.56
▸ TUBA1B P68363 2/20 0.56
▸ TUBA4A P68366 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503998 1.00 TPMT (1.00) TPMTPTGS2CA12CA1CA2
SCHEMBL22824410 0.90 TPMT (0.81) TPMTPTGS2CA12CA1CA2
SCHEMBL793706 0.88 TPMT (0.78) TPMTPTGS2CA12CA1CA2
3,4,5-Trimethoxybenzoic Acid SCHEMBL6592 0.88 TPMT (0.78) TPMTPTGS2CA12CA1CA2
SCHEMBL25359586 0.87 TPMT (0.77) TPMTPTGS2CA12CA1CA2
3,4,5-Trimethoxybenzoic Acid SCHEMBL11023602 0.86 TPMT (0.75) TPMTPTGS2CA12CA1CA2
3,4,5-Trimethoxybenzoic Acid SCHEMBL4080846 0.86 TPMT (0.75) TPMTPTGS2CA12CA1CA2
3,4,5-Trimethoxybenzoic Acid SCHEMBL10838612 0.86 TPMT (0.75) TPMTPTGS2CA12CA1CA2
3,4,5-Trimethoxybenzoic Acid SCHEMBL9739818 0.86 TPMT (0.75) TPMTPTGS2CA12CA1CA2
SCHEMBL12245712 0.85 TPMT (0.73) TPMTPTGS2HTTTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076610-A Macrocyclic compounds with ENT1 inhibitory activity ITEOS比利时公司 2024-05-24 — — CN disclosed
CN-116535365-A Macrocyclic diamine derivatives and their combination with adenosine receptor antagonists as ENT inhibitors for the treatment of cancer ITEOS比利时公司 2023-08-04 — — CN disclosed
EP-4132933-A1 MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS iTeos Belgium SA (BE) 2023-02-15 — — EP disclosed
Send feedback